From the 2022 Joint Annual
Meeting (recorded 6/28/2022)
Presented by Amy
Bogue, MLS(ASCP)CM, SM(ASCP)CM, Jeffrey Kugelman,
PhD, Matthew Conte, PhD, Kimberly Bishop-Lilly, PhD, Anthony Fries, PhD and Christopher
Myers, PhD
Discover how clinical specimens
are selected for sequencing and variant analysis in military labs. Considerable
planning is required to align the military’s unique requirements for a highly
mobile force with Center for Disease Control and Prevention (CDC) initiatives
and other Global Emerging Infections Surveillance (GEIS) stakeholders and
partners. Get an overview of GEIS and the integration with clinical specimen
submissions. Discuss your questions with a knowledgeable panel of
representatives from several large military laboratories with a mixture of
clinical and research testing missions.
LEARNING OBJECTIVES
At the conclusion of this presentation,
participants will be able to:
- Summarize the scope of work done by the DoD for emerging infectious disease surveillance at several large military labs with whole genome sequencing capabilities.
- Identify the criteria used in selecting specimens for SARS-CoV-2 whole genome sequencing and variant analysis.
- Discuss surveillance questions or questions about SARS-CoV-2 whole genome sequencing with a panel of representatives from large Army, Navy and Air Force labs.
CE ACCREDITATION
ASCLS is approved as a provider of continuing
education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ®
Program. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the
area of GEN (General) will be awarded to
participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of
Certification and all states, including Florida and California, as an approved
provider of continuing education for recertification and licensure. ASCLS is an
approved provider with CE Broker for Florida licensees.
LEVEL OF INSTRUCTION
This Intermediate-level
program is appropriate for laboratory professionals working in clinical, public
health and academic settings.